Category Archives: Business and Investments

Latest From Business and Investments

Life Science Leader Asks: What is the Role VCs Play in Partnering with Small Biotech?

Life Science Leader

When Peter Young began planning his session proposal for this year’s BIO International Conference, the executive-in-residence with A.M. Pappas & Associates, like many submitters hoping to serve as 2015 BIO change agents, wanted to create a session worthy of your time. While I am sure you will find the session he will be moderating fascinating (Inventing Your Own Hub: Evolving Institutional Models for Translational Medicine, June 16, 3:30 PM – 4:45 PM, Room 105AB), Young, a Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Innovation Zone Company Snapshot: Arytha Biosciences

BIO Innovation Zone

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Science foundation (NSF) and the National Institutes of Health (NIH) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Morning Consult: Right-Sized Regulations, Innovation and Investor Protection

Jim Greenwood

Today, an op-ed from BIO President and CEO Jim Greenwood appeared in Morning Consult stressing the importance of investor protection by reforming eXtensible Business Reporting Language (XBRL), which is a one-size-fits-all costly reporting requirement that can harm company growth and investor returns. Congressman Robert Hurt (R-VA) introduced a bill – the Small Company Disclosure Simplification Act (H.R. 1965) – that would provide a temporary exemption from XBRL for newly public and low-revenue companies in order Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Innovation Zone Company Snapshots: ONL Therapeutics and Lipella Pharmaceuticals

BIO Innovation Zone

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process prior Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO BizLink Approaches Milestone as Convention Approaches

BIO_BizLink_logo

In less than a year’s time, BIO BizLink, BIO’s peer-rated CRO/CMO database and project management tool, has attracted nearly 1,000 companies looking to connect in the pre-clinical and clinical contract research space! In a recent survey of biotech companies, all of those that responded indicated that they were maintaining or increasing their contract service budget over the coming year. As the industry’s largest event, the 2015 BIO International Convention in Philadelphia is perfect for meeting Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , ,